<?xml version="1.0" encoding="utf-8"?>
<!-- Generator: Adobe Illustrator 15.0.2, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.0//EN" "http://www.w3.org/TR/2001/REC-SVG-20010904/DTD/svg10.dtd">
<svg version="1.0" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px"
	 width="841.89px" height="595.276px" viewBox="0 0 841.89 595.276" enable-background="new 0 0 841.89 595.276"
	 xml:space="preserve">
<path opacity="0.25" fill="#2A00FF" d="M786.5,308.779c0,4.772-10.161,8.645-22.687,8.645H563.383
	c-12.534,0-22.695-3.872-22.695-8.645v-46.104c0-4.773,10.161-8.644,22.695-8.644h200.431c12.525,0,22.687,3.87,22.687,8.644
	V308.779z"/>
<path opacity="0.25" fill="#FF0000" d="M847,152.272c0,11.725-10.191,21.228-22.763,21.228H579.606
	c-12.571,0-22.757-9.503-22.757-21.228V24.903c0-11.727,10.186-21.23,22.757-21.23h244.631c12.571,0,22.763,9.503,22.763,21.23
	V152.272z"/>
<path opacity="0.25" fill="#00FF03" d="M200.887,176.5c0,7.579-6.316,13.726-14.101,13.726H19.938c-7.788,0-14.1-6.146-14.1-13.726
	v-81.21c0-7.581,6.313-13.725,14.1-13.725h166.849c7.785,0,14.101,6.144,14.101,13.725V176.5z"/>
<linearGradient id="SVGID_4_" gradientUnits="userSpaceOnUse" x1="7.3335" y1="212.6299" x2="77.9404" y2="212.6299">
	<stop  offset="0" style="stop-color:#FFFFFF"/>
	<stop  offset="1" style="stop-color:#000000"/>
</linearGradient>
<rect x="7.333" y="193.996" opacity="0.35" fill="url(#SVGID_4_)" stroke="#000000" stroke-width="2.4272" width="70.607" height="37.268"/>
<path opacity="0.25" fill="#00FF03" d="M386.853,175.304c0,7.313-6.152,13.235-13.741,13.235H219.71
	c-7.589,0-13.739-5.923-13.739-13.235v-79.41c0-7.311,6.15-13.236,13.739-13.236h153.402c7.588,0,13.741,5.925,13.741,13.236
	V175.304z"/>
<g opacity="0.35">
	
		<image overflow="visible" opacity="0.75" width="180" height="95" xlink:href="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAALUAAABgCAYAAABboDM1AAAACXBIWXMAAAsSAAALEgHS3X78AAAA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" transform="matrix(1 0 0 1 527.7021 187.7646)">
	</image>
	<g>
		<linearGradient id="SVGID_7_" gradientUnits="userSpaceOnUse" x1="548.4746" y1="218.1602" x2="651.9746" y2="218.1602">
			<stop  offset="0" style="stop-color:#FFFFFF"/>
			<stop  offset="1" style="stop-color:#000000"/>
		</linearGradient>
		<rect x="548.475" y="209.151" fill="url(#SVGID_7_)" width="103.5" height="18.018"/>
		<rect x="548.475" y="209.151" fill="none" stroke="#000000" stroke-width="2.4272" width="103.5" height="18.018"/>
	</g>
</g>
<g opacity="0.35">
	
		<image overflow="visible" opacity="0.75" width="180" height="94" xlink:href="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAALUAAABfCAYAAACujIZNAAAACXBIWXMAAAsSAAALEgHS3X78AAAA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" transform="matrix(1 0 0 1 684.7021 185.7646)">
	</image>
	<g>
		<linearGradient id="SVGID_10_" gradientUnits="userSpaceOnUse" x1="705.5068" y1="215.7031" x2="809.0078" y2="215.7031">
			<stop  offset="0" style="stop-color:#FFFFFF"/>
			<stop  offset="1" style="stop-color:#000000"/>
		</linearGradient>
		<rect x="705.507" y="206.695" fill="url(#SVGID_10_)" width="103.501" height="18.016"/>
		<rect x="705.507" y="206.695" fill="none" stroke="#000000" stroke-width="2.4272" width="103.501" height="18.016"/>
	</g>
</g>
<linearGradient id="SVGID_13_" gradientUnits="userSpaceOnUse" x1="398.5767" y1="218.9795" x2="502.0771" y2="218.9795">
	<stop  offset="0" style="stop-color:#FFFFFF"/>
	<stop  offset="1" style="stop-color:#000000"/>
</linearGradient>
<rect x="398.577" y="209.97" opacity="0.35" fill="url(#SVGID_13_)" stroke="#000000" stroke-width="2.4272" width="103.5" height="18.018"/>
<g opacity="0.35">
	
		<image overflow="visible" opacity="0.75" width="180" height="94" xlink:href="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAALUAAABfCAYAAACujIZNAAAACXBIWXMAAAsSAAALEgHS3X78AAAA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" transform="matrix(1 0 0 1 250.2031 188.2632)">
	</image>
	<g>
		<linearGradient id="SVGID_15_" gradientUnits="userSpaceOnUse" x1="270.9888" y1="218.1602" x2="374.4878" y2="218.1602">
			<stop  offset="0" style="stop-color:#FFFFFF"/>
			<stop  offset="1" style="stop-color:#000000"/>
		</linearGradient>
		<rect x="270.989" y="209.151" fill="url(#SVGID_15_)" width="103.499" height="18.018"/>
		<rect x="270.989" y="209.151" fill="none" stroke="#000000" stroke-width="2.4272" width="103.499" height="18.018"/>
	</g>
</g>
<linearGradient id="SVGID_18_" gradientUnits="userSpaceOnUse" x1="108.6011" y1="220.6162" x2="212.1006" y2="220.6162">
	<stop  offset="0" style="stop-color:#FFFFFF"/>
	<stop  offset="1" style="stop-color:#000000"/>
</linearGradient>
<rect x="108.601" y="211.609" opacity="0.35" fill="url(#SVGID_18_)" stroke="#000000" stroke-width="2.4272" width="103.5" height="18.015"/>
<line fill="none" stroke="#000000" stroke-width="1.2136" x1="75.331" y1="213.247" x2="105.924" y2="213.247"/>
<line fill="none" stroke="#000000" stroke-width="1.2136" x1="216.561" y1="220.616" x2="272.773" y2="220.616"/>
<line fill="none" stroke="#000000" stroke-width="1.2136" x1="373.595" y1="218.16" x2="399.47" y2="218.16"/>
<line fill="none" stroke="#000000" stroke-width="1.2136" x1="504.753" y1="217.342" x2="542.227" y2="217.342"/>
<line fill="none" stroke="#000000" stroke-width="1.2136" x1="651.975" y1="216.522" x2="705.507" y2="216.522"/>
<line fill="none" stroke="#000000" stroke-width="1.2136" x1="96.635" y1="190.315" x2="96.635" y2="212.429"/>
<line fill="none" stroke="#000000" stroke-width="1.2136" x1="250.466" y1="187.971" x2="250.466" y2="219.013"/>
<text transform="matrix(1.0895 0 0 1 543.6367 265.9785)"><tspan x="0" y="0" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">Dysplasia and cancer classifications:</tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">“Negative for dysplasia”.</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">”Indefinite for dysplasia”.</tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">“High grade dysplasia”.</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">”Intermucosal adenocarcinoma”.</tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">“Invasive adenocarcinoma”.</tspan></text>
<g>
	<g>
		<path fill="none" stroke="#000000" stroke-width="2.4272" d="M562.923,203.83c-15.926-25.738-46.513-20.487-65.55,0.549"/>
		<path d="M487.544,215.24c2.729-6.827,5.231-16.096,5.363-23.125l5.756,10.839l11.357,4.649
			C503.039,208.433,494.064,211.845,487.544,215.24z"/>
	</g>
</g>
<path opacity="0.25" fill="#FF0000" d="M423.817,67.029c0,5.933-10.437,10.742-23.313,10.742H35.309
	C22.435,77.771,12,72.962,12,67.029V10.63C12,4.7,22.435-0.111,35.309-0.111h365.196c12.875,0,23.313,4.811,23.313,10.742V67.029z"
	/>
<path opacity="0.25" fill="#FF0000" d="M555.618,116.439c0,8.87-4.599,16.061-10.272,16.061H434.952
	c-5.673,0-10.27-7.191-10.27-16.061v-96.37c0-8.872,4.597-16.063,10.27-16.063h110.394c5.674,0,10.272,7.191,10.272,16.063V116.439z
	"/>
<rect x="313.326" y="255.659" fill="none" stroke="#000000" width="220.722" height="332.95"/>
<path opacity="0.2" stroke="#000000" stroke-width="0.6765" d="M128.079,522.769c0,1.227-0.992,2.219-2.219,2.219h-9.945
	c-1.225,0-2.219-0.992-2.219-2.219v-7.723c0-1.225,0.994-2.219,2.219-2.219h9.945c1.227,0,2.219,0.994,2.219,2.219V522.769z"/>
<g>
	<path fill="none" stroke="#000000" stroke-width="6.7649" d="M150.434,496.286c1.098,12.646,0.908,25.334,1.779,37.979"/>
	<path fill="none" stroke="#000000" stroke-width="0.6765" d="M149.864,536.028c-1.855,1.844-4.105,3.877-5.285,6.459"/>
	<path fill="none" stroke="#000000" stroke-width="0.6765" d="M151.04,536.028c-0.104,2.934-1.27,5.404-1.762,8.221"/>
	<path fill="none" stroke="#000000" stroke-width="0.6765" d="M152.801,537.202c-0.242,2.043,0.086,4.17,1.176,5.873"/>
	<path fill="none" stroke="#000000" stroke-width="0.6765" d="M154.563,536.614c1.338,1.58,2.9,3.063,2.938,5.287"/>
	<path fill="none" stroke="#000000" stroke-width="0.6765" d="M141.594,496.419c1.197,10.082,1.197,20.082,1.197,30.082c0,4-2,4-4,7
		c-4,11,1,23-4,34c-8,14-26,9-37,2c-5-3-10,0-12.529,3.525"/>
	<path fill="none" stroke="#000000" stroke-width="0.6765" d="M155.149,496.577c1.643,4.924,0.643,9.924,2.643,14.924c1,4-1,9,0,13
		c1,2,1,6,2,5c4-2,9-3,14-3c6,11,8,25,2,37c-2,3-6,3-7,7c-22,8-48,19-71,7c-3-2-8-3-11.355,2.574"/>
	<radialGradient id="SVGID_40_" cx="151.7319" cy="527.0645" r="5.5079" gradientUnits="userSpaceOnUse">
		<stop  offset="0" style="stop-color:#FFFFFF"/>
		<stop  offset="1" style="stop-color:#000000"/>
	</radialGradient>
	<ellipse fill="url(#SVGID_40_)" cx="151.732" cy="527.063" rx="7.7" ry="1.176"/>
	<line fill="none" stroke="#67AE24" stroke-width="0.6765" x1="150.036" y1="532.677" x2="142.987" y2="536.591"/>
	<line fill="none" stroke="#324A96" stroke-width="2.0295" x1="154.473" y1="543.899" x2="164.393" y2="570.005"/>
	<g>
		<g>
			<line fill="none" stroke="#324A96" stroke-width="2.0295" x1="164.393" y1="570.005" x2="141.682" y2="543.899"/>
			<path fill="#324A96" d="M133.643,534.658c5.396,2.945,12.842,5.945,18.665,6.753l-9.571,3.701l-4.99,8.967
				C137.753,548.2,135.813,540.41,133.643,534.658z"/>
		</g>
	</g>
	<line fill="none" stroke="#67AE24" stroke-width="2.0295" x1="157.083" y1="543.118" x2="168.047" y2="576.271"/>
	<g>
		<g>
			<line fill="none" stroke="#67AE24" stroke-width="2.0295" x1="168.047" y1="576.271" x2="142.987" y2="552.776"/>
			<path fill="#67AE24" d="M134.051,544.399c5.667,2.382,13.379,4.61,19.254,4.823l-9.146,4.653l-4.054,9.427
				C139.515,557.454,136.794,549.9,134.051,544.399z"/>
		</g>
	</g>
</g>
<rect x="4.659" y="255.327" fill="none" stroke="#000000" width="303.389" height="332.95"/>
<rect x="2" fill="none" stroke="#000000" stroke-width="3" width="848.277" height="595.388"/>
<rect x="561.483" y="329.538" fill="none" width="248.59" height="33.087"/>
<text transform="matrix(1.0895 0 0 1 561.4834 346.5781)" font-family="'MyriadPro-BoldIt'" font-size="24">Barrett’s Oesophagus</text>
<rect x="320.548" y="272.938" fill="none" width="143.12" height="50.227"/>
<text transform="matrix(1.0929 0 0 1 320.5483 278.6172)"><tspan x="0" y="0" font-family="'MyriadPro-BoldIt'" font-size="8">1. Path reporting types</tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">Grades</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8"> 0-No CLO/IM</tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8"> 1-CLO/no IM</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8"> 2-CLO plus IM</tspan></text>
<rect x="57.375" y="180.066" fill="none" width="138.999" height="9.771"/>
<text transform="matrix(1 0 0 1 57.375 185.0361)" font-family="'MyriadPro-Regular'" font-size="7">BO develops in &lt;1 year with no progression</text>
<rect x="113.063" y="216.522" fill="none" width="98.147" height="13.546"/>
<text transform="matrix(1.0895 0 0 1 113.0625 223.4995)" font-family="'MyriadPro-Regular'" font-size="9.8274">Barrett’s Oesophagitis</text>
<rect x="277.234" y="216.522" fill="none" width="99.038" height="13.384"/>
<text transform="matrix(1.0895 0 0 1 277.2339 223.4995)" font-family="'MyriadPro-Regular'" font-size="9.8274">Intestinal Metaplasia</text>
<rect x="405.718" y="214.065" fill="none" width="95.467" height="13.708"/>
<text transform="matrix(1.0895 0 0 1 405.7178 221.0425)" font-family="'MyriadPro-Regular'" font-size="9.8274">Low Grade Dysplasia</text>
<rect x="551.151" y="212.428" fill="none" width="95.47" height="13.708"/>
<text transform="matrix(1.0895 0 0 1 551.1514 219.4058)" font-family="'MyriadPro-Regular'" font-size="9.8274">High Grade Dysplasia</text>
<rect x="711.756" y="212.428" fill="none" width="81.194" height="10.627"/>
<text transform="matrix(1.0895 0 0 1 711.7559 219.4058)" font-family="'MyriadPro-Regular'" font-size="9.8274">Adenocarcinoma</text>
<rect x="85.33" y="216.56" fill="none" width="18.342" height="8.537"/>
<text transform="matrix(1 0 0 1 85.3296 222.5708)" font-family="'MyriadPro-Bold'" font-size="8.4659">10%</text>
<rect x="380.069" y="220.037" fill="none" width="13.404" height="8.537"/>
<text transform="matrix(1 0 0 1 380.0688 226.0474)" font-family="'MyriadPro-Bold'" font-size="8.4659">5%</text>
<rect x="507.058" y="208.75" fill="none" width="36.686" height="22.036"/>
<text transform="matrix(1 0 0 1 507.0576 214.7603)"><tspan x="0" y="0" font-family="'MyriadPro-Bold'" font-size="8.4659">15% over </tspan><tspan x="0" y="10.159" font-family="'MyriadPro-Bold'" font-size="8.4659">2 yrs</tspan></text>
<rect x="669.321" y="219.53" fill="none" width="18.343" height="8.536"/>
<text transform="matrix(1 0 0 1 669.3213 225.541)" font-family="'MyriadPro-Bold'" font-size="8.4659">50%</text>
<rect x="383.258" y="231.372" fill="none" width="140.778" height="24.9"/>
<text transform="matrix(1 0 0 1 383.2583 237.0518)"><tspan x="0" y="0" font-family="'MyriadPro-Regular'" font-size="8">Risk of adenocarcinoma 0.6 %/yr  if </tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">experts disagree or 50% if 3 experts agree</tspan></text>
<rect x="655.012" y="232.814" fill="none" width="58.989" height="24.9"/>
<text transform="matrix(1 0 0 1 655.0117 239.418)"><tspan x="0" y="0" font-family="'MyriadPro-Regular'" font-size="9.3012">Rate of cancer </tspan><tspan x="0" y="11.162" font-family="'MyriadPro-Regular'" font-size="9.3012">is 5%/yr</tspan></text>
<rect x="18.333" y="4.062" fill="none" width="209.668" height="77.503"/>
<text transform="matrix(1 0 0 1 18.3335 14.002)" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">Management of Barrett’s</text>
<text transform="matrix(1.0895 0 0 1 18.3335 23.6021)" font-family="'MyriadPro-Regular'" font-size="8">Patients need PPI . </text>
<text transform="matrix(1.0895 0 0 1 18.3335 33.2017)" font-family="'MyriadPro-Regular'" font-size="8">Surveillance endoscopy:</text>
<text transform="matrix(1.0895 0 0 1 18.3335 42.8018)" font-family="'MyriadPro-Regular'" font-size="8">-If gastric metaplasia and &lt;3cm rpt OGD then?d/c</text>
<text transform="matrix(1.0895 0 0 1 18.3335 52.4019)" font-family="'MyriadPro-Regular'" font-size="8">-If IM and &lt;3cm then rpt OGD 3-5 yrs</text>
<text transform="matrix(1.0895 0 0 1 18.3335 62.002)" font-family="'MyriadPro-Regular'" font-size="8">-If &gt;3cm rpt OGD 2-3 yrs regardless of IM</text>
<text transform="matrix(1 0 0 1 18.3335 71.6021)" font-family="'MyriadPro-Regular'" font-size="8">-PPI’s cause partial BO regression with squamous islands.</text>
<rect x="558.85" y="8.184" fill="none" width="286.428" height="118.316"/>
<text transform="matrix(1 0 0 1 558.8496 18.124)"><tspan x="0" y="0" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">Management of High Grade Dysplasia Options:</tspan><tspan x="0" y="9.6" font-family="'MyriadPro-BoldIt'" font-size="8">Oesophagectomy.</tspan><tspan x="62.79" y="9.6" font-family="'MyriadPro-Regular'" font-size="8"> </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-BoldIt'" font-size="8">Endoscopic ablative therapies </tspan><tspan x="104.492" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">— Patients are then maintained on PPI.</tspan><tspan x="0" y="48" font-family="'MyriadPro-BoldIt'" font-size="8" letter-spacing="34">	</tspan><tspan x="36" y="48" font-family="'MyriadPro-BoldIt'" font-size="8">Radiofrequency ablation</tspan><tspan x="121.511" y="48" font-family="'MyriadPro-Regular'" font-size="8"> —using balloon causing circumferential or </tspan><tspan x="0" y="57.6" font-family="'MyriadPro-Regular'" font-size="8">focussed Barrett’s eradication.</tspan><tspan x="0" y="67.2" font-family="'MyriadPro-BoldIt'" font-size="8" letter-spacing="34">	</tspan><tspan x="36" y="67.2" font-family="'MyriadPro-BoldIt'" font-size="8">Photodynamic therapy</tspan><tspan x="114.972" y="67.2" font-family="'MyriadPro-Regular'" font-size="8"> which is better than omeprazole alone for </tspan><tspan x="0" y="76.8" font-family="'MyriadPro-Regular'" font-size="8">eradicating dysplasia and preventing cancer.</tspan><tspan x="0" y="105.6" font-family="'MyriadPro-BoldIt'" font-size="8" letter-spacing="34">	</tspan><tspan x="36" y="105.6" font-family="'MyriadPro-BoldIt'" font-size="8">Endoscopic mucosal resection.</tspan></text>
<rect x="320.779" y="356.636" fill="none" width="211.269" height="271.364"/>
<text transform="matrix(1.0929 0 0 1 320.7788 362.3154)" font-family="'MyriadPro-BoldIt'" font-size="8">2. Classified by</text>
<text transform="matrix(1.0929 0 0 1 376.2949 362.3154)" font-family="'MyriadPro-Regular'" font-size="8"> </text>
<text transform="matrix(1.0929 0 0 1 378.1484 362.3154)" font-family="'MyriadPro-BoldIt'" font-size="8">Length</text>
<text transform="matrix(1.0929 0 0 1 320.7788 371.916)" font-family="'MyriadPro-Regular'" font-size="8"> a Long segment &gt;3cm</text>
<text transform="matrix(1.0929 0 0 1 320.7788 381.5156)" font-family="'MyriadPro-Regular'" font-size="8"> b Short segment &lt; 3cm (more common often asympto</text>
<text transform="matrix(1.0929 0 0 1 521.2012 381.5156)" font-family="'MyriadPro-Regular'" font-size="8">-</text>
<text transform="matrix(1.0929 0 0 1 320.7788 391.1152)" font-family="'MyriadPro-Regular'" font-size="8">matic</text>
<text transform="matrix(1.0929 0 0 1 320.7788 400.7158)" font-family="'MyriadPro-Regular'" font-size="8"> c Intestinal metaplasia at the cardia</text>
<text transform="matrix(1.0929 0 0 1 320.7788 410.3154)" font-family="'MyriadPro-BoldIt'" font-size="8">2. Classified by histology</text>
<text transform="matrix(1.0031 0 0 1 320.7788 419.916)" font-family="'MyriadPro-BoldIt'" font-size="8">-Junctional type epithelium</text>
<text transform="matrix(1.0031 0 0 1 415.229 419.916)" font-family="'MyriadPro-Regular'" font-size="8">, Pitted surface and mucus-</text>
<text transform="matrix(1.0031 0 0 1 320.7788 429.5156)" font-family="'MyriadPro-Regular'" font-size="8">secreting cells (looks like gastric cardia)</text>
<text transform="matrix(1.0031 0 0 1 320.7788 439.1152)" font-family="'MyriadPro-BoldIt'" font-size="8">-Gastric fundic-type epithelium</text>
<text transform="matrix(1.0031 0 0 1 427.9404 439.1152)" font-family="'MyriadPro-Regular'" font-size="8"> Pitted surface and mucus-</text>
<text transform="matrix(1.0031 0 0 1 320.7788 448.7158)" font-family="'MyriadPro-Regular'" font-size="8">secreting cells and a deeper glandular layer containing chief </text>
<text transform="matrix(1.0031 0 0 1 320.7788 458.3154)" font-family="'MyriadPro-Regular'" font-size="8">and parietal cells (looks like gastric fundus)</text>
<text transform="matrix(1.0031 0 0 1 320.7788 467.916)" font-family="'MyriadPro-BoldIt'" font-size="8">-Specialized intestinal metaplasia</text>
<text transform="matrix(1.0031 0 0 1 437.1045 467.916)" font-family="'MyriadPro-Regular'" font-size="8"> (= specialized columnar </text>
<text transform="matrix(1.0031 0 0 1 320.7788 477.5156)" font-family="'MyriadPro-Regular'" font-size="8">epithelium), which has intestinal-type crypts lined by </text>
<text transform="matrix(1.0031 0 0 1 320.7788 487.1152)" font-family="'MyriadPro-Regular'" font-size="8">mucus-secreting columnar cells and goblet cells (best way to </text>
<text transform="matrix(1.0031 0 0 1 320.7788 496.7158)" font-family="'MyriadPro-Regular'" font-size="8">distinguish from other types) and villi. </text>
<text transform="matrix(1.0031 0 0 1 320.7788 506.3154)" font-family="'MyriadPro-Regular'" font-size="8">Can also have gastric-type cells, small intestinal-like cells, and </text>
<text transform="matrix(1.0031 0 0 1 320.7788 515.916)" font-family="'MyriadPro-Regular'" font-size="8">colonic-like columnar cells, endocrine and Paneth cells.</text>
<text transform="matrix(1.0031 0 0 1 320.7788 525.5156)" font-family="'MyriadPro-Regular'" font-size="8">Indistinguishable histologically from IM type II or III of the </text>
<text transform="matrix(1.0031 0 0 1 320.7788 535.1152)" font-family="'MyriadPro-Regular'" font-size="8">stomach.</text>
<text transform="matrix(1.0031 0 0 1 320.7788 544.7158)" font-family="'MyriadPro-Regular'" font-size="8">The goblet cells of specialized intestinal metaplasia contain </text>
<text transform="matrix(1.0031 0 0 1 320.7788 554.3154)" font-family="'MyriadPro-Regular'" font-size="8">acidic mucins (sialomucins and sulfomucins) stain with Alcian </text>
<text transform="matrix(1.0031 0 0 1 320.7788 563.916)" font-family="'MyriadPro-Regular'" font-size="8">blue +/-  colonic-like mucins -stain with high-iron diamine.</text>
<text transform="matrix(1 0 0 1 320.7788 573.5156)" font-family="'MyriadPro-Regular'" font-size="8">IM more important than gastric metaplasia for cancer risk and </text>
<text transform="matrix(1 0 0 1 320.7788 583.1152)" font-family="'MyriadPro-Regular'" font-size="8">likely to be present in long segment BO.</text>
<rect x="428.772" y="6.494" fill="none" width="126.077" height="129.402"/>
<text transform="matrix(1 0 0 1 428.7725 16.4336)" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">Management of Low </text>
<text transform="matrix(1 0 0 1 428.7725 33.2334)" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">Grade Dysplasia</text>
<text transform="matrix(1.0895 0 0 1 428.7725 52.4336)" font-family="'MyriadPro-Regular'" font-size="8">If LGD then 6 monthly biopsies are </text>
<text transform="matrix(1.0895 0 0 1 428.7725 62.0337)" font-family="'MyriadPro-Regular'" font-size="8">needed.</text>
<text transform="matrix(1 0 0 1 428.7725 71.6333)" font-family="'MyriadPro-Regular'" font-size="8">If LGD is not found on repeat </text>
<text transform="matrix(1 0 0 1 428.7725 81.2334)" font-family="'MyriadPro-Regular'" font-size="8">biopsies, then yearly endoscopy is </text>
<text transform="matrix(1 0 0 1 428.7725 90.8335)" font-family="'MyriadPro-Regular'" font-size="8">warranted until no dysplasia is </text>
<text transform="matrix(1 0 0 1 428.7725 100.4336)" font-family="'MyriadPro-Regular'" font-size="8">present on 2 consecutive annual </text>
<text transform="matrix(1 0 0 1 428.7725 110.0337)" font-family="'MyriadPro-Regular'" font-size="8">endoscopies.</text>
<text transform="matrix(1 0 0 1 428.7725 119.6333)" font-family="'MyriadPro-Regular'" font-size="8">Radiofrequency ablation can be </text>
<text transform="matrix(1 0 0 1 428.7725 129.2334)" font-family="'MyriadPro-Regular'" font-size="8">considered in selected cases</text>
<rect x="377.668" y="283.999" fill="none" width="112.5" height="67.985"/>
<text transform="matrix(1.0929 0 0 1 377.668 289.6787)"><tspan x="0" y="0" font-family="'MyriadPro-Regular'" font-size="8"> 3-CLO + no IM-circumferential</tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8"> 4-CLO + IM-circumferential</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8"> B Combination with </tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">endoscopic diagnosis for CLO</tspan><tspan x="0" y="38.399" font-family="'MyriadPro-Regular'" font-size="8"> C In keeping but not specific </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">for CLO</tspan><tspan x="0" y="57.6" font-family="'MyriadPro-Regular'" font-size="8"> D No evident CLO</tspan></text>
<rect x="336.659" y="258.993" fill="none" width="126.667" height="19.667"/>
<text transform="matrix(1.0929 0 0 1 336.6592 268.9326)" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">Barrett’s subtypes:</text>
<rect x="17.405" y="390.334" fill="none" width="292.72" height="87.666"/>
<text transform="matrix(1 0 0 1 17.4053 400.2734)"><tspan x="0" y="0" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">Methods of assessing dysplasia in Barrett’s</tspan><tspan x="0" y="14.4" font-family="'MyriadPro-BoldIt'" font-size="8">Autofluorescence endoscopy for Barrett&apos;s oesophagus</tspan><tspan x="184.564" y="14.4" font-family="'MyriadPro-BoldIt'" font-size="12"> </tspan><tspan x="186.772" y="14.4" font-family="'MyriadPro-Regular'" font-size="8">are of two  types-Light-induced </tspan><tspan x="0" y="24" font-family="'MyriadPro-Regular'" font-size="8">fluorescence spectroscopy (LIFS) and Autofluorescence endoscopy (AFE).</tspan><tspan x="0" y="33.601" font-family="'MyriadPro-BoldIt'" font-size="8">The role of autofluorescence </tspan><tspan x="98.684" y="33.601" font-family="'MyriadPro-Regular'" font-size="8">is unclear.</tspan><tspan x="0" y="43.2" font-family="'MyriadPro-BoldIt'" font-size="8">Narrow band imaging may be useful in Barrett&apos;s oesophagus to identify irregular </tspan><tspan x="0" y="52.801" font-family="'MyriadPro-BoldIt'" font-size="8">mucosal pattern and abnormal vasculature.</tspan><tspan x="0" y="62.4" font-family="'MyriadPro-BoldIt'" font-size="8">Zoom endoscopy provides higher definition.</tspan><tspan x="0" y="72" font-family="'MyriadPro-BoldIt'" font-size="8">Spectroscopy (which is OCT based) is in development.</tspan></text>
<rect x="184.999" y="513.222" fill="none" width="47.682" height="40.657"/>
<text transform="matrix(1 0 0 1 184.9985 518.9014)"><tspan x="0" y="0" font-family="'MyriadPro-BoldIt'" font-size="8">RGB filter</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-Regular'" font-size="8">Seperates </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">white light </tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">into primaries</tspan></text>
<rect x="114.129" y="514.198" fill="none" width="24.662" height="18.946"/>
<text transform="matrix(1 0 0 1 114.1294 519.8779)"><tspan x="0" y="0" font-family="'MyriadPro-BoldIt'" font-size="8">CCD </tspan><tspan x="0" y="9.601" font-family="'MyriadPro-BoldIt'" font-size="8">Device </tspan></text>
<rect x="46.54" y="508.327" fill="none" width="80.141" height="59.96"/>
<text transform="matrix(1 0 0 1 46.5396 514.0068)"><tspan x="0" y="0" font-family="'MyriadPro-BoldIt'" font-size="8">CCD device </tspan><tspan x="39.912" y="0" font-family="'MyriadPro-Regular'" font-size="8">detects </tspan><tspan x="0" y="9.601" font-family="'MyriadPro-Regular'" font-size="8">reflected light</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">Blue light reflects </tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">superficial mucosa and </tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">vessels (Hb absorbs </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">blue light)</tspan></text>
<rect x="93.667" y="231.667" fill="none" width="160.333" height="11.771"/>
<text transform="matrix(1.0031 0 0 1 93.6665 237.6592)" font-family="'MyriadPro-Regular'" font-size="8.4397">Oesophageal adenocarcinoma risk 0.5%/year</text>
<rect x="12" y="84.677" fill="none" width="184.374" height="82.134"/>
<text transform="matrix(1.0895 0 0 1 12 94.6172)"><tspan x="0" y="0" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">Risk factors for conversion </tspan><tspan x="0" y="16.8" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">from reflux to Barrett&apos;s:</tspan><tspan x="0" y="26.4" font-family="'MyriadPro-Regular'" font-size="8"> Hiatus Hernia.</tspan><tspan x="0" y="36" font-family="'MyriadPro-Regular'" font-size="8"> LOS failure (90%).</tspan><tspan x="0" y="45.6" font-family="'MyriadPro-Regular'" font-size="8"> Peristaltic failure (70%).</tspan><tspan x="0" y="55.2" font-family="'MyriadPro-Regular'" font-size="8"> High acid exposure.</tspan><tspan x="0" y="64.8" font-family="'MyriadPro-Regular'" font-size="8"> Impaired mucosal sensitivity.</tspan></text>
<rect x="207.874" y="85" fill="none" width="189" height="82.04"/>
<text transform="matrix(1.0895 0 0 1 207.874 94.9399)"><tspan x="0" y="0" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">Risk factors for conversion </tspan><tspan x="0" y="16.8" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">of Barrett&apos;s to IM:</tspan><tspan x="0" y="26.4" font-family="'MyriadPro-Regular'" font-size="8">Being &gt; than 45 years old.</tspan><tspan x="0" y="36" font-family="'MyriadPro-Regular'" font-size="8">Having &gt; 8cm length of Barrett&apos;s.</tspan><tspan x="0" y="45.6" font-family="'MyriadPro-Regular'" font-size="8">Early onset GORD.</tspan><tspan x="0" y="55.2" font-family="'MyriadPro-Regular'" font-size="8">Long duration of reflux.</tspan><tspan x="0" y="64.8" font-family="'MyriadPro-Regular'" font-size="8">Having duodeno-oesophageal reflux.</tspan></text>
<rect x="15.218" y="483.836" fill="none" width="260.333" height="127.353"/>
<text transform="matrix(1 0 0 1 15.2178 489.5156)"><tspan x="0" y="0" font-family="'MyriadPro-BoldIt'" font-size="8">Study 1</tspan><tspan x="25.601" y="0" font-family="'MyriadPro-Regular'" font-size="8">: HGIN exhibited at least irregular mucosal patterns, irregular vascular </tspan><tspan x="0" y="9.601" font-family="'MyriadPro-Regular'" font-size="8">patterns, or abnormal blood vessels. </tspan></text>
<rect x="548.475" y="374.001" fill="none" width="261.525" height="160.623"/>
<text transform="matrix(1.0929 0 0 1 548.4746 383.9404)" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14"> Barrett&apos;s definition and epidemiology </text>
<text transform="matrix(1.0929 0 0 1 548.4746 393.541)" font-family="'MyriadPro-Regular'" font-size="8">Barrett’s is defined as any part of the normal squamous lined oesoph</text>
<text transform="matrix(1.0929 0 0 1 801.4287 393.541)" font-family="'MyriadPro-Regular'" font-size="8">-</text>
<text transform="matrix(1.0929 0 0 1 548.4746 403.1406)" font-family="'MyriadPro-Regular'" font-size="8">gus is replaced with metaplastic columnar epithelium above the GOJ </text>
<text transform="matrix(1.0929 0 0 1 548.4746 412.7412)" font-family="'MyriadPro-Regular'" font-size="8">(3cm).</text>
<text transform="matrix(1 0 0 1 548.4746 422.3408)" font-family="'MyriadPro-Regular'" font-size="8">The average age at diagnosis is55.</text>
<text transform="matrix(1 0 0 1 548.4746 431.9404)" font-family="'MyriadPro-Regular'" font-size="8">Barrett’s is rare in blacks and asians.</text>
<text transform="matrix(1 0 0 1 548.4746 441.541)" font-family="'MyriadPro-Regular'" font-size="8">The M:F prevalence is 2:1.</text>
<text transform="matrix(1 0 0 1 548.4746 451.1406)" font-family="'MyriadPro-Regular'" font-size="8">The prevalence is 2% but10% if the patient has heartburn.</text>
<text transform="matrix(1 0 0 1 548.4746 460.7412)" font-family="'MyriadPro-Regular'" font-size="8">The endoscopic sensitivity is &gt; 80 %..</text>
<text transform="matrix(1 0 0 1 548.4746 479.9404)" font-family="'MyriadPro-BoldIt'" font-size="8">Diagnostic Criteria include </text>
<text transform="matrix(1 0 0 1 641.2822 479.9404)" font-family="'MyriadPro-Regular'" font-size="8">columnar epithelium in the distal oesophagus </text>
<text transform="matrix(1 0 0 1 548.4746 489.541)" font-family="'MyriadPro-Regular'" font-size="8">(accuracy 80%).</text>
<text transform="matrix(1 0 0 1 548.4746 499.1406)" font-family="'MyriadPro-Regular'" font-size="8">Intestinal metaplasia is necessary for the diagnosis in the US only.</text>
<text transform="matrix(1 0 0 1 548.4746 508.7412)" font-family="'MyriadPro-Regular'" font-size="8">The endoscopic measurement is given by Prague staging consisting of C </text>
<text transform="matrix(1 0 0 1 548.4746 518.3408)" font-family="'MyriadPro-Regular'" font-size="8">(distance to circumferential Barrett’s from GOJ) and M (distance of Barrett’s </text>
<text transform="matrix(1 0 0 1 548.4746 527.9404)" font-family="'MyriadPro-Regular'" font-size="8">tongues from GOJ) distances.</text>
<rect x="559.333" y="40.667" fill="none" width="205.667" height="21.075"/>
<text transform="matrix(1 0 0 1 559.333 46.3467)"><tspan x="0" y="0" font-family="'MyriadPro-Regular'" font-size="8">May not eradicate all dysplasia, and may hide metaplasia </tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">under healed squamous tissue</tspan></text>
<rect x="558.331" y="100" fill="none" width="179.667" height="19.316"/>
<text transform="matrix(1 0 0 1 558.3311 105.6797)"><tspan x="0" y="0" font-family="'MyriadPro-Regular'" font-size="8">15 % of PDT patients still develop esophageal cancer.</tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">PDT can cause strictures</tspan></text>
<rect x="679.025" y="568.324" fill="none" width="144.773" height="16.731"/>
<text transform="matrix(1 0 0 1 679.0254 576.8438)" fill="#009540" font-family="'MyriadPro-Regular'" font-size="12">Written by Dr Sebastian Zeki</text>
<rect x="9" y="200.116" fill="none" width="68.5" height="31.943"/>
<text transform="matrix(1 0 0 1 9 208.6357)"><tspan x="0" y="0" font-family="'MyriadPro-Regular'" font-size="12">Reflux </tspan><tspan x="0" y="14.4" font-family="'MyriadPro-Regular'" font-size="12">oesophagitis</tspan></text>
<rect x="15.634" y="300.335" fill="none" width="282.5" height="89.999"/>
<text transform="matrix(1 0 0 1 15.6338 310.2744)"><tspan x="0" y="0" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">Methods of describing Barrett’s endoscopically</tspan><tspan x="0" y="9.601" font-family="'MyriadPro-BoldIt'" font-size="8">1. Prague criteria</tspan><tspan x="59.03" y="9.601" font-family="'MyriadPro-Regular'" font-size="8"> (C=circumferential proximal margin M = proximal limit of tongues. </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">Both measured above the hiatus hernia (measured as the distance from the top of </tspan><tspan x="0" y="28.801" font-family="'MyriadPro-Regular'" font-size="8">the gastric folds to the Z-line).</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-BoldIt'" font-size="8">2. Paris criteria</tspan><tspan x="51.526" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">- to describe lesions- see early gastric cancer.</tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">Should all be assessed with HD scope and mucolytics. Spend 1min/cm</tspan><tspan x="0" y="57.601" font-family="'MyriadPro-Regular'" font-size="8">Dont over-insufflate</tspan><tspan x="0" y="67.2" font-family="'MyriadPro-Regular'" font-size="8">Most lesions between 12 and  o’clock</tspan><tspan x="0" y="76.801" font-family="'MyriadPro-Regular'" font-size="8">CLO tongue should be at least 1cm to be called Barrett’s. </tspan></text>
<rect x="212.101" y="5.5" fill="none" width="208.844" height="39.167"/>
<text transform="matrix(1 0 0 1 212.1006 15.4399)"><tspan x="0" y="0" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">Management of Indefinite for </tspan><tspan x="0" y="16.8" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">dysplasia</tspan><tspan x="0" y="26.4" font-family="'MyriadPro-Regular'" font-size="8">Rebiopsy at  6 months.</tspan></text>
<g>
	<g>
		<line fill="none" stroke="#000000" x1="393.473" y1="217.342" x2="393.473" y2="67.652"/>
		<g>
			<path d="M393.473,69.447l-3.603,2.191l-0.082-0.123l2.334-5.875c0.45-2.047,0.9-4.094,1.351-6.141
				c0.451,2.047,0.9,4.094,1.352,6.141l2.333,5.875l-0.061,0.123L393.473,69.447z"/>
		</g>
	</g>
</g>
<rect x="562.85" y="180.497" fill="none" width="148.007" height="17.5"/>
<text transform="matrix(1 0 0 1 562.8496 186.1768)" font-family="'MyriadPro-Regular'" font-size="8">All these patients need high res endoscopy</text>
<rect x="211" y="44.667" fill="none" width="171.65" height="26.675"/>
<text transform="matrix(1 0 0 1 211 50.3467)"><tspan x="0" y="0" font-family="'MyriadPro-Regular'" font-size="8">Atypia with ulcer or inflammation OR if surface not </tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">visible OR not mature (last one= Basal crypt </tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">dysplasia- managed as per LGD </tspan></text>
<rect x="16.54" y="257.5" fill="none" width="116.386" height="11.326"/>
<text transform="matrix(1 0 0 1 16.5396 267.4395)" fill="#FF0000" font-family="'MyriadPro-BoldIt'" font-size="14">Screening Barrett’s</text>
<rect x="16" y="271.228" fill="none" width="282.134" height="34.5"/>
<text transform="matrix(1 0 0 1 16 276.9072)"><tspan x="0" y="0" font-family="'MyriadPro-Regular'" font-size="8">Consider in high risk groups (symptomatic white, obese males or those with FDR </tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">with oesophageal ca or Barrett’s.</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">Methods include endoscopic or cytosponge/ biomarkers in development</tspan></text>
<rect x="743" y="118" fill="none" width="95" height="58.5"/>
<text transform="matrix(1 0 0 1 743 123.6797)"><tspan x="0" y="0" font-family="'MyriadPro-Regular'" font-size="8">Ideal lesions:</tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">HGD/IMC</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">&lt;3cm in size</tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">Good tumour differentiation</tspan><tspan x="0" y="38.4" font-family="'MyriadPro-Regular'" font-size="8">No lymphatic/ vascular </tspan><tspan x="0" y="48" font-family="'MyriadPro-Regular'" font-size="8">invasion</tspan></text>
<g>
	<g>
		<line fill="none" stroke="#000000" x1="714.001" y1="126.02" x2="729.846" y2="126.02"/>
		<g>
			<path d="M728.051,126.02l-2.191-3.603l0.123-0.082l5.875,2.334c2.047,0.45,4.094,0.9,6.141,1.351
				c-2.047,0.451-4.094,0.9-6.141,1.352l-5.875,2.333l-0.123-0.061L728.051,126.02z"/>
		</g>
	</g>
</g>
<rect x="593.5" y="131" fill="none" width="120.501" height="36.5"/>
<text transform="matrix(1 0 0 1 593.5 136.6797)"><tspan x="0" y="0" font-family="'MyriadPro-Regular'" font-size="8">Can be done with a) lift+cut b) Band </tspan><tspan x="0" y="9.6" font-family="'MyriadPro-Regular'" font-size="8">ligator c)En bloc resection.</tspan><tspan x="0" y="19.2" font-family="'MyriadPro-Regular'" font-size="8">ER+ RFA (seperate sessions) better </tspan><tspan x="0" y="28.8" font-family="'MyriadPro-Regular'" font-size="8">than ER alone.</tspan></text>
</svg>
